Precision Optics Corporation, Inc. (POCI)
USD 4.2
(4.22%)
USD 4.2
(4.22%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -2.95 Million USD | -1940.88% |
| 2023 | -144.61 Thousand USD | 84.42% |
| 2022 | -928.41 Thousand USD | -802.82% |
| 2021 | -102.83 Thousand USD | 92.79% |
| 2020 | -1.42 Million USD | -131.94% |
| 2019 | -614.87 Thousand USD | -74.98% |
| 2018 | -351.39 Thousand USD | 65.09% |
| 2017 | -1 Million USD | 2.74% |
| 2016 | -1.03 Million USD | 12.22% |
| 2015 | -1.17 Million USD | -1.56% |
| 2014 | -1.16 Million USD | 35.08% |
| 2013 | -1.78 Million USD | -286.03% |
| 2012 | 960.97 Thousand USD | 191.29% |
| 2011 | -1.05 Million USD | -59.27% |
| 2010 | -660.88 Thousand USD | 33.39% |
| 2009 | -992.13 Thousand USD | 38.88% |
| 2008 | -1.62 Million USD | 43.83% |
| 2007 | -2.88 Million USD | -27.17% |
| 2006 | -2.27 Million USD | 38.39% |
| 2005 | -3.68 Million USD | -0.12% |
| 2004 | -3.68 Million USD | -25.83% |
| 2003 | -2.92 Million USD | 70.64% |
| 2002 | -9.97 Million USD | -166.53% |
| 2001 | -3.74 Million USD | -73.57% |
| 2000 | -2.15 Million USD | -26.82% |
| 1999 | -1.7 Million USD | 15.0% |
| 1998 | -2 Million USD | -400.0% |
| 1997 | -400 Thousand USD | -200.0% |
| 1996 | 400 Thousand USD | -33.33% |
| 1995 | 600 Thousand USD | 0.0% |
| 1994 | - USD | 100.0% |
| 1993 | -1.3 Million USD | -1200.0% |
| 1992 | -100 Thousand USD | -150.0% |
| 1991 | 200 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -758.8 Thousand USD | -63.39% |
| 2024 Q4 | -1.41 Million USD | -345.07% |
| 2024 Q1 | -464.41 Thousand USD | -383.14% |
| 2024 Q3 | -317.05 Thousand USD | 58.22% |
| 2023 Q4 | -96.12 Thousand USD | 72.67% |
| 2023 Q3 | -351.72 Thousand USD | -169.15% |
| 2023 Q2 | 508.66 Thousand USD | 489.98% |
| 2023 Q1 | -130.43 Thousand USD | -113.45% |
| 2023 FY | -144.61 Thousand USD | 84.42% |
| 2022 Q4 | 970.06 Thousand USD | 682.0% |
| 2022 FY | -928.41 Thousand USD | -802.82% |
| 2022 Q1 | -576.8 Thousand USD | -30.36% |
| 2022 Q2 | -507.01 Thousand USD | 12.1% |
| 2022 Q3 | -166.67 Thousand USD | 67.13% |
| 2021 Q2 | -213.45 Thousand USD | -27017.28% |
| 2021 Q4 | -442.45 Thousand USD | -180.11% |
| 2021 FY | -102.83 Thousand USD | 92.79% |
| 2021 Q1 | 793.00 USD | 100.25% |
| 2021 Q3 | 552.27 Thousand USD | 358.73% |
| 2020 Q3 | -466.13 Thousand USD | 15.38% |
| 2020 Q1 | -86.11 Thousand USD | 21.11% |
| 2020 FY | -1.42 Million USD | -131.94% |
| 2020 Q4 | -323.08 Thousand USD | 30.69% |
| 2020 Q2 | -550.82 Thousand USD | -539.68% |
| 2019 Q1 | -299.28 Thousand USD | -1861.33% |
| 2019 Q2 | -125.94 Thousand USD | 57.92% |
| 2019 Q4 | -109.15 Thousand USD | -35.62% |
| 2019 FY | -614.87 Thousand USD | -74.98% |
| 2019 Q3 | -80.48 Thousand USD | 36.1% |
| 2018 Q4 | 16.99 Thousand USD | 106.08% |
| 2018 FY | -351.39 Thousand USD | 65.09% |
| 2018 Q1 | -28.78 Thousand USD | 87.89% |
| 2018 Q2 | -60.32 Thousand USD | -109.57% |
| 2018 Q3 | -279.27 Thousand USD | -362.94% |
| 2017 Q3 | -163.35 Thousand USD | 47.66% |
| 2017 FY | -1 Million USD | 2.74% |
| 2017 Q1 | -293.4 Thousand USD | -96.3% |
| 2017 Q2 | -312.09 Thousand USD | -6.37% |
| 2017 Q4 | -237.6 Thousand USD | -45.45% |
| 2016 FY | -1.03 Million USD | 12.22% |
| 2016 Q3 | -222.09 Thousand USD | 21.05% |
| 2016 Q2 | -281.31 Thousand USD | 26.34% |
| 2016 Q1 | -381.89 Thousand USD | -5.13% |
| 2016 Q4 | -149.46 Thousand USD | 32.7% |
| 2015 Q3 | -197.88 Thousand USD | 38.4% |
| 2015 FY | -1.17 Million USD | -1.56% |
| 2015 Q2 | -321.22 Thousand USD | -8.36% |
| 2015 Q1 | -296.43 Thousand USD | 6.49% |
| 2015 Q4 | -363.24 Thousand USD | -83.57% |
| 2014 Q1 | -210.72 Thousand USD | -21.73% |
| 2014 Q3 | -380.43 Thousand USD | -50.69% |
| 2014 FY | -1.16 Million USD | 35.08% |
| 2014 Q2 | -252.45 Thousand USD | -19.8% |
| 2014 Q4 | -317.03 Thousand USD | 16.67% |
| 2013 Q1 | -358.09 Thousand USD | -62.43% |
| 2013 Q4 | -173.1 Thousand USD | 50.54% |
| 2013 Q2 | -906.48 Thousand USD | -153.14% |
| 2013 Q3 | -349.99 Thousand USD | 61.39% |
| 2013 FY | -1.78 Million USD | -286.03% |
| 2012 FY | 960.97 Thousand USD | 191.29% |
| 2012 Q3 | -492.13 Thousand USD | -51.49% |
| 2012 Q2 | -324.87 Thousand USD | -116.26% |
| 2012 Q1 | 1.99 Million USD | 864.21% |
| 2012 Q4 | -220.45 Thousand USD | 55.2% |
| 2011 FY | -1.05 Million USD | -59.27% |
| 2011 Q1 | -157.84 Thousand USD | -196.34% |
| 2011 Q2 | -330.95 Thousand USD | -109.67% |
| 2011 Q3 | -302.31 Thousand USD | 8.65% |
| 2011 Q4 | -261.5 Thousand USD | 13.5% |
| 2010 Q4 | -53.26 Thousand USD | 59.45% |
| 2010 Q2 | -304.09 Thousand USD | -76.65% |
| 2010 Q3 | -131.36 Thousand USD | 56.8% |
| 2010 Q1 | -172.15 Thousand USD | -2.96% |
| 2010 FY | -660.88 Thousand USD | 33.39% |
| 2009 Q1 | -426.94 Thousand USD | -27.87% |
| 2009 FY | -992.13 Thousand USD | 38.88% |
| 2009 Q2 | -173.86 Thousand USD | 59.28% |
| 2009 Q3 | -224.13 Thousand USD | -28.91% |
| 2009 Q4 | -167.19 Thousand USD | 25.4% |
| 2008 FY | -1.62 Million USD | 43.83% |
| 2008 Q2 | -693.46 Thousand USD | -48.54% |
| 2008 Q1 | -466.84 Thousand USD | 21.48% |
| 2008 Q4 | -333.88 Thousand USD | -158.51% |
| 2008 Q3 | -129.16 Thousand USD | 81.37% |
| 2007 Q3 | -843.91 Thousand USD | -10.58% |
| 2007 FY | -2.88 Million USD | -27.17% |
| 2007 Q4 | -594.55 Thousand USD | 29.55% |
| 2007 Q2 | -763.18 Thousand USD | -10.9% |
| 2007 Q1 | -688.17 Thousand USD | -15.85% |
| 2006 Q2 | -636.39 Thousand USD | -13.67% |
| 2006 Q1 | -559.87 Thousand USD | 49.75% |
| 2006 FY | -2.27 Million USD | 38.39% |
| 2006 Q4 | -594.03 Thousand USD | -23.2% |
| 2006 Q3 | -482.17 Thousand USD | 24.23% |
| 2005 Q2 | -820.87 Thousand USD | 12.06% |
| 2005 Q4 | -1.11 Million USD | -35.88% |
| 2005 Q3 | -819.91 Thousand USD | 0.12% |
| 2005 Q1 | -933.45 Thousand USD | 7.72% |
| 2005 FY | -3.68 Million USD | -0.12% |
| 2004 Q1 | -636.44 Thousand USD | 36.87% |
| 2004 Q4 | -1.01 Million USD | 0.57% |
| 2004 Q3 | -1.01 Million USD | 0.15% |
| 2004 Q2 | -1.01 Million USD | -60.07% |
| 2004 FY | -3.68 Million USD | -25.83% |
| 2003 Q1 | -791.89 Thousand USD | 40.52% |
| 2003 Q4 | -1 Million USD | -141.93% |
| 2003 Q3 | -416.71 Thousand USD | 41.39% |
| 2003 Q2 | -710.98 Thousand USD | 10.22% |
| 2003 FY | -2.92 Million USD | 70.64% |
| 2002 FY | -9.97 Million USD | -166.53% |
| 2002 Q2 | -1.99 Million USD | 63.76% |
| 2002 Q1 | -5.5 Million USD | -311.15% |
| 2002 Q3 | -1.14 Million USD | 42.82% |
| 2002 Q4 | -1.33 Million USD | -16.68% |
| 2001 Q1 | -435.99 Thousand USD | -29.24% |
| 2001 FY | -3.74 Million USD | -73.57% |
| 2001 Q3 | -1.11 Million USD | -29.8% |
| 2001 Q4 | -1.33 Million USD | -20.54% |
| 2001 Q2 | -855.89 Thousand USD | -96.31% |
| 2000 FY | -2.15 Million USD | -26.82% |
| 2000 Q4 | -337.34 Thousand USD | 49.47% |
| 2000 Q3 | -667.66 Thousand USD | 4.62% |
| 2000 Q2 | -700 Thousand USD | -40.0% |
| 2000 Q1 | -500 Thousand USD | 16.67% |
| 1999 FY | -1.7 Million USD | 15.0% |
| 1999 Q1 | -400 Thousand USD | 42.86% |
| 1999 Q2 | -300 Thousand USD | 25.0% |
| 1999 Q3 | -400 Thousand USD | -33.33% |
| 1999 Q4 | -600 Thousand USD | -50.0% |
| 1998 FY | -2 Million USD | -400.0% |
| 1998 Q4 | -700 Thousand USD | -75.0% |
| 1998 Q1 | -400 Thousand USD | 20.0% |
| 1998 Q2 | -500 Thousand USD | -25.0% |
| 1998 Q3 | -400 Thousand USD | 20.0% |
| 1997 Q3 | -300 Thousand USD | -400.0% |
| 1997 Q1 | 300 Thousand USD | 50.0% |
| 1997 Q4 | -500 Thousand USD | -66.67% |
| 1997 FY | -400 Thousand USD | -200.0% |
| 1997 Q2 | 100 Thousand USD | -66.67% |
| 1996 FY | 400 Thousand USD | -33.33% |
| 1996 Q2 | - USD | -100.0% |
| 1996 Q1 | 200 Thousand USD | -33.33% |
| 1996 Q4 | 200 Thousand USD | 100.0% |
| 1996 Q3 | 100 Thousand USD | 0.0% |
| 1995 Q4 | 300 Thousand USD | 50.0% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 FY | 600 Thousand USD | 0.0% |
| 1995 Q3 | 200 Thousand USD | 100.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q1 | -100 Thousand USD | 85.71% |
| 1994 Q2 | - USD | 100.0% |
| 1994 FY | - USD | 100.0% |
| 1994 Q4 | - USD | -100.0% |
| 1993 Q1 | -200 Thousand USD | 0.0% |
| 1993 Q4 | -700 Thousand USD | -600.0% |
| 1993 Q3 | -100 Thousand USD | 50.0% |
| 1993 FY | -1.3 Million USD | -1200.0% |
| 1993 Q2 | -200 Thousand USD | 0.0% |
| 1992 FY | -100 Thousand USD | -150.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 FY | 200 Thousand USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 95.339% |
| AngioDynamics, Inc. | -184.34 Million USD | 98.399% |
| AtriCure, Inc. | -30.43 Million USD | 90.304% |
| Avinger, Inc. | -18.32 Million USD | 83.89% |
| Azenta, Inc. | -14.25 Million USD | 79.299% |
| BioLife Solutions, Inc. | -66.42 Million USD | 95.557% |
| The Cooper Companies, Inc. | 294.2 Million USD | 101.003% |
| Daxor Corporation | 280.64 Thousand USD | 1151.659% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 80.58% |
| Femasys Inc. | -14.24 Million USD | 79.284% |
| GlucoTrack, Inc. | -7.09 Million USD | 58.414% |
| Harvard Bioscience, Inc. | -3.41 Million USD | 13.576% |
| Hologic, Inc. | 789.5 Million USD | 100.374% |
| ICU Medical, Inc. | -29.65 Million USD | 90.048% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.164% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 78.521% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 109.804% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 55.708% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 55.708% |
| Masimo Corporation | 81.5 Million USD | 103.621% |
| Microbot Medical Inc. | -10.74 Million USD | 72.52% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 125.387% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 103.126% |
| Nephros, Inc. | -1.57 Million USD | -87.389% |
| NovoCure Limited | -207.04 Million USD | 98.575% |
| NEXGEL, Inc. | -3.15 Million USD | 6.513% |
| NEXGEL, Inc. | -3.15 Million USD | 6.513% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 96.887% |
| OraSure Technologies, Inc. | 53.65 Million USD | 105.501% |
| Pro-Dex, Inc. | 2.12 Million USD | 238.758% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 93.008% |
| Predictive Oncology Inc. | -13.98 Million USD | 78.895% |
| QuidelOrtho Corporation | -10.1 Million USD | 70.778% |
| Repligen Corporation | 41.57 Million USD | 107.099% |
| Sanara MedTech Inc. | -4.3 Million USD | 31.414% |
| STAAR Surgical Company | 21.34 Million USD | 113.826% |
| Sharps Technology, Inc. | -9.84 Million USD | 70.011% |
| Utah Medical Products, Inc. | 16.63 Million USD | 117.742% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 97.764% |
| Jin Medical International Ltd. | 2.87 Million USD | 202.541% |